Abstract-Oxidized low density lipoproteins (Ox-LDLs) are increasingly thought to be a key element in atherogenesis. We have previously reported that serum albumin has important antioxidant properties and that a reduced synthesis of albumin may represent a crucial point in the overall antioxidant defense. In the present work, we aimed at determining whether Ox-LDL could modulate albumin synthesis in cultured human hepatocytes (HepG2 cells). With the use of enzyme immunoassay and radiolabeled leucine incorporation followed by specific immunoprecipitation, Ox-LDL was found to lead to a dose-dependent decrease in albumin secretion. Moreover, the protein synthesis and mRNA levels were decreased in the presence of Ox-LDL, as assessed by Northern blot analysis. Because oxysterols and lysophospholipids are key components of Ox-LDL, we tested the effects of oxysterols (7-ketocholesterol and 25-hydroxycholesterol) and lysophosphatidylcholine on albumin secretion and expression. In our experimental conditions, we found that incubations with oxysterols or lysophosphatidylcholine at pathophysiological concentrations similar to those measured in Ox-LDLs reproduced the above-mentioned inhibitory effects on albumin synthesis. On the basis of our in vitro data, we propose that this newly described biological effect of Ox-LDL might partly explain the findings of epidemiological studies indicating that reduced levels of serum albumin are associated with increased mortality. (Arterioscler Thromb Vasc
O xidant stress is increasingly thought to be a key element in atherogenesis. Atherosclerosis is a complex multifactorial disease caused by an excessive accumulation of lipids in the vascular wall. These lipids are essentially found in foam cells, which result from the transformation of smooth muscle cells and macrophages. 1 By damaging the lipids contained in LDLs, free radicals generate proatherogenic oxidized particles. 2, 3 These antioxidant-depleted oxidized lipid-enriched lipoproteins accumulate polyunsaturated fatty acid breakdown substances that secondarily react with the apoB of LDL. These modified LDLs are no longer recognized by their classic LDL receptors but by scavenger receptors, which are not downregulated by excess cholesterol. 4 This oxidative stress hypothesis is reinforced by data provided by various studies on the beneficial effects of lipid-soluble antioxidants. [5] [6] [7] Indeed, although a precise cause-and-effect relationship between the susceptibility of LDL to oxidation and the potential benefits of antioxidant therapy with respect to vascular lesion development and/or reduction has not yet been established, particularly in clinical trials, studies in animals and humans indicate that supplementation with antioxidants increases the resistance of LDL to oxidation.
Among compounds formed during oxidation are the products of cholesterol auto-oxidation (oxysterols). 8 Oxysterols are found in foods, 9 human lipoproteins, 10 and various tissues. 11 They have a wide range of biological effects, all of which may be of importance for atherosclerosis. 12 Oxysterols have been shown to inhibit cholesterol biosynthesis by downregulating the activity of 3-hydroxy-3-methylglutaryl coenzyme A reductase (EC 1.1.1.34), to decrease the number of LDL receptors on cells, to enhance cholesterol ester accumulation by activation of acyl coenzyme A:cholesteryl acyltransferase (EC 2.3.1.26), to alter membrane permeability, 13 to modulate platelet function, 14 and to induce experimental atherosclerosis. 15 Lysophospholipid is also one of the active molecules generated during oxidative modification of LDL. Lysophosphatidylcholine (LPC) has been reported to mediate several of the proinflammatory effects of oxidized LDL (Ox-LDL), to stimulate smooth muscle cell proliferation, and to induce several endothelial genes expressed in the atherosclerotic arterial wall. 16, 17 LPC, which has also been identified in experimentally induced atherosclerotic lesions in animals, has been shown to be chemotactic. 18 Albumin represents the most abundant serum protein, with normal concentrations lying between 35 and 50 g/L. Many epidemiological studies have established an inverse relationship between serum albumin level and mortality risk. In diseased populations as well as in the general population, it has been estimated that the odds of death increases from 24% to 56% for each 2.5-g/L decrement in the initial albumin level (see review 19 ). This association holds also for cardiovascular disease after adjustment for the usual risk factors. 20 Among a variety of biological mechanisms that have been proposed to explain the beneficial effects of higher albumin concentrations, a direct protective effect of the albumin molecule has been suggested. There is now evidence for a significant antioxidant activity of serum albumin. In fact, this molecule may represent the major and predominant circulating antioxidant in plasma that is known to be exposed to continuous oxidative stress. 21 Albumin may thus represent a quantitatively important component of the efficient antioxidant defense that organisms have developed to protect against oxidative attack. 22 Moreover, our recent data bring further support to the proposal that in addition to its plasma concentration, the quality of the albumin molecule may be related to its biological properties. 23 We reported that glucose and free radicals impair the antioxidant properties of serum albumin. The serum level of albumin is mainly related to its synthesis and catabolism but also to its transcapillary escape. Variation in albumin concentration may reflect variation in the nutritional state. In fact, only a small number of factors are known to result in variation in serum albumin. Beside analbuminemia, a rare congenital disease, 24 the nephrotic syndrome is the main pathological situation known to lower albumin concentration. 25 In addition, it has been reported that serum albumin concentration decreases with age and cigarette smoking, 20 2 well-documented oxidative-related conditions.
In the present work, we first investigated the effects of native LDL (N-LDL) and modified LDL on albumin synthesis in the human hepatoma cell line, HepG2. We found that contrary to incubation with N-LDL and acetylated LDL (Ac-LDL), only incubation with oxidatively modified LDL drastically reduced albumin secretion. We then examined the effects of some lipid oxidation products found in oxidized lipoproteins, such as oxysterols and LPC, on albumin synthesis and mRNA expression.
Methods

Cell Culture
HepG2 cells were grown in a CO 2 incubator (5% CO 2 /95% air) in a 75-cm 2 flask (Polylabo). Cultures were maintained in 20 mL DMEM (GIBCO) containing 10% FCS, 1.25% L-glutamine, and 2% penicillin/streptomycin. About 5 or 6 days before each experiment, Ϸ1 million cells were seeded in 6-well tissue clusters (Costar) in 3 mL DMEM containing 10% FCS. Incubations were performed in 10% lipoprotein-deficient FCS (LPDS) and with the indicated amounts of LDL preparations or various molecules. Cell viability was assayed by using lactate dehydrogenase (LDH) released in the medium (Sigma, procedure 500).
LDL Preparation and Modification
LDLs (1.019 to 1.055 g/mL) were isolated by sequential ultracentrifugation of pooled plasma from normolipidemic subjects (Beckman centrifuge). After dialysis against PBS (pH 7.4), LDLs were assayed for protein content with bicinchoninic acid (Pierce). OxLDLs were obtained by incubating 100 g/mL protein LDL with 25 mol/L CuSO 4 at 37°C overnight. Ac-LDLs were prepared from N-LDLs by the addition of acetic anhydride in the presence of cold saturated sodium acetate. 26 LDL integrity or modifications were evaluated by determining (1) the content of thiobarbituric acidreactive substances, (2) lipid peroxides by using the iodine reagent, 27 and (3) the chromophore fluorescence at 430 nm after excitation at 355 nm. 2 Agarose gel electrophoresis (0.5%) was performed with a Beckman Paragon lipoprotein electrophoresis kit. 28 Before use, LDLs were dialyzed against high-glucose or leucine-poor DMEM (5% of the leucine of the normal medium).
Cholesterol, Oxysterols, and Fatty Acid Analysis
Sterols and oxysterols were obtained from Sigma or Steraloids, except for 7␣-and 7␤-cholesterol, which were synthesized as described in our previous study. 29 When necessary (purity Ͻ95%), the oxysterols were repurified by thin-layer chromatography on silica gel-impregnated plates (Merck) with hexane/ethyl acetate (70:30 [vol/vol]), and purity was checked by gas chromatography. 29 Oxysterols were added to cell media in ethanol (0.05%, final concentration). After incubation with oxysterols (usually for 14 hours at 5 g/mL), cells were thoroughly washed with PBS. Total lipid extracts were carried out according to Folch et al 30 and analyzed according to our previous technique. 29 
Studies on Secretion of HSA by HepG2 Cells
Assay of HSA by ELISA Samples of culture medium were assayed for human serum albumin (HSA) by a competitive ELISA that made use of a specific peroxidase-conjugated rabbit antihuman albumin (Dako). The ELISA was linear over a concentration range of 0.15 to 20 g/mL of HSA with an intraplaque variation coefficient that did not exceed 6% and with a correlation coefficient Ͼ0.990. The concentration of HSA was expressed as micrograms per microgram of cellular DNA. 31 
Immunoprecipitations
For immunoprecipitation studies, incubation was performed in leucine-poor DMEM (5% of the leucine of normal medium) containing 5 Ci/mL [ 3 H]leucine (Amersham). The antibody was a rabbit monospecific anti-human albumin antibody (Dako). In brief, medium was first precleared by 1 hour of incubation with 100 L washed protein A Sepharose (10 mg/mL, Pharmacia). After centrifugation, 100 L of the medium was added to 200 L PBS and 100 L anti-HSA antibodies (1:20 dilution). After a 1-hour incubation on ice, 100 L of protein A Sepharose (10 mg/mL) was added to Net buffer, which contained 30 mmol/L Tris-HCl, 150 mmol/L NaCl, 0.5% (vol/vol) NP-40, and 2 mmol/L EDTA (pH 8). The precipitated HSA-immunocomplex was isolated by centrifugation. After 3 washes in Net buffer, pellets were dissolved in glycine buffer (0.1 mol/L, pH 3), and an aliquot was used for radioactivity assay. The incorporation of [ 3 H]leucine in albumin was expressed as disintegrations per minute per microgram cellular DNA. The specificity of this immunoprecipitation technique was examined by analyzing HSA immunocomplexes by 12% SDS-PAGE.
Pulse Labeling
In pulse-chase protocol, and for each sample, two 6-well plates (plate A for pulse labeling and plate B for pulse-chase labeling) were seeded with HepG2 cells. The cells were grown in DMEM/FCS until they reached confluence, and each plate was washed with PBS. DMEM with 10% LPDS containing 200 g/mL native LDL, Ac-LDL, or Ox-LDL was added, and incubation was continued for 14 hours. The medium was then removed, and cells were incubated for 20 minutes in leucine-depleted DMEM. Thereafter, leucine-poor medium containing 5 Ci/mL [ 3 H]leucine was added for pulse labeling for a 15-minute incubation period. After pulse labeling of plate A, the medium was removed, and the cells were washed with cold PBS. After being pelleted, the cells were mixed with 1 mL lysis buffer containing 100 L 10ϫ protease-inhibitor mix (PIM, containing 186 mg EDTA, 35 mg phenylmethylsulfonyl fluoride, 1 mg antipain, and 1 mg pepstatin A per 50 mL) and 250 L 5-fold concentrated PBS-TDS (containing 47.25 g NaCl, 7 g Na 2 HPO 4 , 1.08 g KH 2 PO 4 , 5 mL Triton X-100, and 2.5 g desoxycholate). After centrifugation for 5 minutes at 4000g, the supernatants were kept frozen at Ϫ20°C for later analysis. After pulse labeling of plate B, the hot medium was removed, and the cells were washed with DMEM and then incubated for 2 hours with DMEM-10% LPDS containing 200 g/mL N-LDL, Ac-LDL, or Ox-LDL (chase incubation). Then the cells were mixed/lysed with PBS-TDS/PIM as described above. The medium was collected and centrifuged (5 minutes, 4000g), and 900 L of the medium was mixed with 100 L of 10ϫ PIM. After pretreatment with protein A Sepharose, the media and cell extracts were subjected to immunoprecipitation as described above.
Quantification of HSA and GAPDH mRNA in HepG2 Cells
Total cellular RNA was isolated from cells with Trizol reagent (Pharmacia). Northern blots were performed as described: 20 g total RNA in 7 L DEPC water was mixed with 26 L sample mix containing 3 L 10ϫ MOPS, 6 L formaldehyde, and 17 L formamide. After 15 minutes at 55°C, samples were loaded with 10 L formaldehyde loading buffer. Electrophoresis was performed in a 1% agarose gel containing 10ϫ MOPS and formaldehyde (15 and 27 mL, respectively, in 108 mL deionized water). Transfer to nylon membrane (0.45 m, Amersham) was realized by capillarity overnight. After being washed and UV-fixed (Stratagene), membranes were stored and dried at room temperature before analysis.
A 258-bp HSA DNA fragment was amplified from human cDNA obtained from HepG2 cells by using the oligonucleotides 5ЈATG ACAACCCAAACCTCCCC3Ј and 5ЈCCTACTTCTCCCCT GAAGCA3Ј. The HSA DNA fragment was ligated into the multiple cloning site of the vector pGEM-T (Promega) SphI plus SalI for the digestion of the cloned fragment and sequenced with the Thermosequenase dye terminator cycle sequencing premix kit (Amersham). The same procedure was used for GAPDH by using the oligonucleotides 5ЈGGAAGGTGAAGGTCGGAGTC3Ј and 5ЈGGAT-GAAGGGAAGGCTTCGT3Ј (SacI plus PstI). Probes were created by labeling DNA fragments with [␣- 32 P]dCTP by use of a random priming kit (Boehringer). Membranes were prehybridized for 3 hours at 42°C in buffer (50% formamide, 5ϫ Denhardt's solution, 5ϫ SSPE, 0.1% SDS, and 100 g/mL salmon sperm DNA). Hybridization was carried out overnight at 42°C in the same buffer to which Ϸ1. 10 6 cpm/mL boiled probe was added. Finally, the membranes were washed 2 times in 6ϫ SSPE/0.5% SDS at room temperature during 15 minutes, 2 times in 1ϫ SSPE/0.5% SDS at 37°C during 15 minutes, and 1 time in 0.1ϫ SSPE/0.1% SDS at 65°C. After film exposure (Kodak X-oMat) and development, radioactive signals were quantified by using Bio1D Software (Vilber-Lourmat). In several occasions, digoxigenin labeling was also used according to the manufacturer's instructions (Boehringer).
Statistical Analyses
Data are expressed as meanϮSD of at least 3 experiments performed in triplicate. Differences between group means were compared by using either the unpaired Student t test for single comparisons or 1-way ANOVA (followed by the Bonferroni test) for multiple comparisons.
Results
Preliminary studies confirmed previous data 32 indicating that HSA was best secreted into the medium when cells reached confluence. Time-course studies of the effects of the various LDL preparations on HSA secretion by confluent HepG2 cells measured by ELISA are illustrated in Figure I (which can be accessed online at http://atvb.ahajournals.org). In the presence of 150 g/mL N-LDL, we observed a significant decrease in HSA compared with control (no LDL), which reached statistical significance (PϽ0.05) only for long (48-hour) incubation times, whereas a marked inhibitory effect of Ox-LDL was obtained as soon as 8 hours (Ϫ22%, Pϭ0.07). The tested LDL concentrations were chosen to be representative of what is encountered in patients with coronary heart disease. 33 It is noteworthy that the secretion was linear for the entire time period studied, with diminishing production rates of 108, 87, and 70 ng/g per hour for control, N-LDL, and Ox-LDL, respectively. The effect of LDL oxidation on HSA production rate was highly significant (PϽ0.001). Conversely, the time dependence of incubations with Ac-LDL led to results similar to those obtained for N-LDL (not shown).
Results of a 14-hour incubation with 2 different amounts of the various LDL preparations on HSA secretion (Figure 1) show that the inhibitory effect of Ox-LDL was dose dependent: Ϫ21% and Ϫ45% for 100 and 200 g/mL, respectively. Under the same incubation conditions (14 hours), Ac-LDL induced a decrease (Ϫ24%) in the secretion of HSA only at a concentration of 200 g/mL.
Additional experiments were designed to examine this HSA secretion by measuring the incorporation of [ 3 H]leucine into HSA secreted into the medium. As assessed by specific immunoprecipitation (Figure 2 ), a significant concentrationdependent decrease in secretion (Ϫ23% and Ϫ34%, respectively; PϽ0.05; nϭ6) was found in the presence of 100 and The results show that the total proteins synthesized did not change with 200 g/mL but, in contrast, increased at 100 g/mL. Theses results confirm the data obtained with LDH release indicating no change between N-LDL and Ox-LDL ( Figure II , which can be accessed online at http://atvb. ahajournals.org). This demonstrates clearly that the Ox-LDLmediated reduction in HSA secretion was specific and not the result of some general toxic effect affecting protein synthesis.
To assess whether Ox-LDL directly affects the rate of protein synthesis and/or intracellular protein turnover, pulsechase experiments were conducted. The cells were first incubated for 14 hours with or without modified LDL, then washed, and pulse-labeled for 15 minutes with [ 3 H]leucine (pulse); the label was then removed, and the cells were either directly processed for synthesized proteins or further incubated for 2 hours in fresh medium without label (chase). As shown in the Table, incorporation of label into HSA during the pulse was lower in cells preincubated with Ox-LDL than in cells incubated with N-LDL (Ϫ22%, PϽ0.01; nϭ6). After the chase incubation, the labeling of HSA in the medium was lower (Ϫ35% versus N-LDL, PϽ0.05; nϭ6) than when cells were preincubated with Ox-LDL. This loss was accounted by a decrease in HSA synthesis because no variation in cellular degradation of HSA (chase as percentage of pulse) was observed in cells preincubated with Ox-LDL. These data clearly indicated that Ox-LDLs lead to a reduced synthesis of HSA rather than an increase in its degradation.
To explore the mechanisms by which Ox-LDL decreases HSA synthesis, we then studied their effects on the level of HSA mRNA by Northern blot analysis. After 14 hours of incubation in the presence of 100 or 200 g/mL Ox-LDL, we found that HSA mRNA levels relative to GAPDH mRNA were decreased by 34% (PϽ0.05) and 46% (PϽ0.01), respectively ( Figure 3A and 3B) . Comparison analysis indicated that under our conditions, N-LDL tended to enhance the HSA/GAPDH mRNA ratio, whereas Ac-LDL slightly inhibited it, particularly at 200 g/mL.
To further understand the difference between the various LDL preparations used, oxidation parameters were analyzed (Table I , which can be accessed online at http://atvb.ahajournals.org). Our data confirm that Ac-LDLs and copperoxidized LDLs have enhanced electrophoretic mobility, relative to that of N-LDLs. Ox-LDLs also have significantly higher conjugated dienes, lipoperoxides, and thiobarbituric acid-reactive substances than do Ac-LDLs and N-LDLs. The level of the chromophore (excitation 355 nm, emission 430 nm) that resulted from the reaction of aldehydic lipid peroxidation products with free amino groups of apoB was strongly enhanced in Ox-LDLs. The lipid composition, summarized in Table II (which can be accessed online at http://atvb.ahajournals.org), indicated that no significant change in Ac-LDL occurred compared with N-LDL, whereas the unsaturation index of Ox-LDL phospholipids was markedly diminished. The total phospholipids were decreased, whereas a significant increase in LPC was observed in Ox-LDL (Ͼ15 times). These changes were also associated with a significant decrease in total cholesterol and a marked appearance of various oxysterols. In particular, as assessed by gas chromatography, we found that 7␤-OH cholesterol, 25-OH cholesterol, 7-ketocholesterol, ␣-epoxy-cholesterol, and cholestanetriol, became massively present in Ox-LDLs.
These data led us to propose that the lipid moiety may play a role in the Ox-LDL-induced decrease in HSA expression. Values are meanϮSD (nϭ6). The experiments were performed in two 6-well plates (1 for pulse and 1 for pulse chase) as described in Methods. To further examine which lipid fraction would be responsible for this activity, lipids were extracted from N-LDL and Ox-LDL and separated as previously described. 29 These experiments were carried out under an oxygen-deprived atmosphere enriched with argon to protect isolated fractions from artifactual oxidation. Results of incubations with these various lipid fractions on HSA secretion by HepG2 cells were analyzed by radioleucine incorporation and immunoprecipitation and are described in Table III (which can be accessed online at http://atvb.ahajournals.org). We found that only the lipid fraction extracted from Ox-LDL was active as compared with that from N-LDL (not shown). The sterol-and the phospholipid-containing fractions, in concentrations encountered in lipoproteins, were able to inhibit the HSA secretion and to reproduce the inhibition observed with Ox-LDL. Furthermore, inhibitions of HSA biosynthesis occurred when cells were incubated with LPC (2 g/mL) and 7-ketocholesterol (5 g/mL) in amounts equivalent to what was measured in 100 g/mL Ox-LDL (Table III , which can be accessed online at http://atvb.ahajournals.org). These results suggest that oxysterols, which are present in high amounts in the sterol-containing fraction, might be the active components involved in the Ox-LDL-mediated impairment of HSA biosynthesis and secretion. To examine this hypothesis, the HSA secretion by HepG2 cells was then studied after incubations with some oxysterols, such as those oxidized either on the sterol ring or on the side chain. As seen in Table III (which can be accessed online at http://atvb.ahajournals.org), the oxysterol concentration found in Ox-LDL was Ϸ9 g per 100 g LDL proteins. Therefore, incubations were carried out for 14 hours with 5 to 10 g/mL of each with ethanol used as a vehicle. The results (Figure 4) indicate that contrary to cholesterol, the different oxysterols, oxidized either on the sterol ring or on the side chain, all reduced HSA secretion by 16% to 32%, as assessed by ELISA, with no evident structure-activity relationship. Similar results, confirming those obtained in Figure 4 , were obtained when HSA production was measured by radiolabeled leucine incorporation and specific immunoprecipitation (not shown). Furthermore, we have measured oxysterol incorporation into HepG2 cells after a 14-hour incubation. Our results indicated that oxysterols did incorporate into cells but in variable amounts (ranging from 16% to 33%), and we found a significant inverse correlation (PϽ0.0025) between levels incorporated and HSA production, as illustrated by the plot of Figure III (which can be accessed online at http://atvb.ahajournals.org). Northern blot analysis of the HSA mRNA performed for LPC and some oxysterols (25-OH and 7-ketocholesterol) indicated that HSA transcripts were reduced in a dosedependent manner relative to GAPDH mRNA ( Figure 5A ). Cholesterol has no effect compared with control incubations. These observations were confirmed by densitometric quantification of RNA ( Figure 5B ).
Synthesis, Intracellular Turnover, and Secretion of HSA in HepG2 as
Discussion
The purpose of the present study was to examine the influence of Ox-LDL on HSA secretion by liver cells to determine whether HSA concentration in plasma is directly associated with mortality risk. We demonstrate that Ox-LDL impairs HSA secretion and synthesis. We also report that some components found in Ox-LDL, such as oxysterols and LPC, are able to reproduce these effects in vitro.
There is now ample evidence of a significant antioxidant activity by serum albumin. 21, 23 Thus, albumin may represent a quantitatively important component in the efficient antiox- Figure 4 , aliquots of total RNA (20 g) isolated from HepG2 cells were electrophoresed, and Northern blot analysis was performed with the use of corresponding cDNA probes specific for HSA or GAPDH as described in Methods. B, Quantitative analysis was performed by scanning of blots and normalized against GAPDH. Results are expressed as percent of control. Statistical significance (nϭ3 to 6) was as follows: *PϽ0.05 and **PϽ0.01 vs corresponding cholesterol concentration or control.
idant defense that organisms have developed to protect against oxidative attack. 22 The beneficial effects of high albumin concentrations hold also for cardiovascular disease after adjustment for the usual risk factors. 20 Most in vitro studies dealing with cell interactions with Ox-LDL have been performed with circulating, endothelial, or vascular cells. In the present study, we report on the effects of Ox-LDL on HSA synthesis by liver cells. Using the human hepatoma-derived cell line HepG2, we found a significant dose-dependent decrease in HSA secretion on incubations with Ox-LDL. This altered synthesis was observed for short incubation times (8 hours). It was not the result of an overall cytotoxic effect, because no change in cell viability was observed, and it was not accompanied by LDH release and by a reduction in total protein synthesis and secretion ( Figure II , which can be accessed online at http://atvb.ahajournals.org), as assessed by normal leucine incorporation. Moreover, these effects on HSA secretion were observed with only 100 g/mL of Ox-LDLs, which constitute a level commonly encountered in dyslipoproteinemic patients. 33 This strengthens the pathophysiological relevance of the findings because it may be possible that liver cells are exposed to such conditions.
Ox-LDLs can promote or suppress expression of different genes. For example, Ox-LDL suppresses the expression of tumor necrosis factor-␣ and interleukin-1␣ in murine peritoneal macrophages and platelet-derived growth factor in human monocytes in cultures. 34 These effects have been convincingly linked to oxidized forms of LDL, whereas N-LDL, Ac-LDL, and malondialdehyde-modified LDL were all inactive. More recently, mildly oxidized LDL has been reported to enhance the genetic expression of extracellular matrix protein 35 and transcription factors. 36 A number of studies also showed that mildly oxidized LDL has important proinflammatory properties that may be responsible for the induction of important inflammatory genes, such as the expression of chemotactic factors, colony-stimulating factors, and tissue factor genes. 37, 38 The products of these genes are known to control recruitment, differentiation, and growth of a number of different cell types found in the artery. 39 In our experimental conditions, the decrease in albumin secretion observed especially with Ox-LDL is due to a decrease in HSA synthesis caused by a reduced level of mRNA encoding for the protein.
During the oxidation process, the various lipids of the LDL particle undergo modification, and an array of oxidation products are generated. Not only do the polyunsaturated fatty acids become oxidized, leading to peroxides, aldehydes, and hydroxy fatty acids, but also part of the cholesterol is transformed into oxysterols, and phospholipids are transformed into lysoderivatives (Table II , which can be accessed online at http://atvb.ahajournals.org). Several of these compounds have important biological properties related to the alteration of vascular lipid metabolism. Cytotoxicity and chemotactic activity have been reported for oxysterols, LPC, and 4-hydroxynonenal. 14, 40, 41 Not surprisingly, many of the various proatherogenic and cell-injuring capacities of Ox-LDL have been attributed to a vast array of these products.
We confirm that LPC is abundant in Ox-LDL, and the presence of this lysoderivative has also been reported in atherosclerotic plaque. 42 LPC is supposed to be generated by the hydrolysis of phosphatidylcholine via LDL-associated phospholipase A 2 activity. 43 We have also recently proposed that LPC present in LDL might result from the activity of secretory phospholipase A 2 released after platelet activation. 44 Several research groups have demonstrated that LPC alters various endothelial functions and induces several endothelial genes expressed in the atherosclerotic arterial wall. Reports describe the induction of intracellular adhesion molecule-1, macrophage chemoattractant protein-1, cyclooxygenase-2, and growth factors in endothelial cells, 16, 17 possibly through modulation of transcription of nuclear factor B via a protein kinase C-mediated pathway. 45 However, some reports suggest that Ox-LDL has opposing effects on the activities of transcription factor activator protein-1, suggesting involvement of mechanisms for transcriptional regulation that are strongly affected by oxysterols rather than LPC. 36 In the present study, we report that a low concentration of LPC, compatible with that found in Ox-LDL from patients, was able to downregulate the HSA biosynthesis and secretion in HepG2 cells.
In our experimental conditions, inhibitory effects of Ox-LDL on albumin synthesis were reproduced with the same concentration of oxysterols found in these modified lipoproteins. Furthermore, we found that oxysterols were incorporated into HepG2 cells, and a significant inverse relationship has been established between cellular oxysterols after incubation and HSA secretion ( Figure III) . Although no simple structure-function relation has been successfully established between oxysterols and HSA secretion, these data also indicate that effects of oxysterols may be related not only to their concentrations but also to their specific incorporation in relation to their physicochemical properties. The mechanism for the downregulation of HSA synthesis appears to be at the transcriptional level, because we found a decrease in the corresponding mRNA. Although specific experiments have to be performed to understand the precise effects of oxysterols in HSA secretion, several in vitro experiments have already shown that oxysterols can reduce protein expression and mRNA levels in cultured cells. 46, 47 Different transcription factors have been shown to be involved in the sterol-mediated regulation of genes involved in cholesterol homeostasis. Most extensive studies have been carried out on the sterol regulatory element binding proteins 1 and 2, which are responsible for the sterol-mediated suppression of the LDL receptor, 3-hydroxy-3-methylglutaryl coenzyme A synthase, and fatty acid synthase genes. 48, 49 More recently, a new class of oxysterol receptors, the liver X nuclear receptor, was shown to be activated by oxysterols, including 7␣-OH, 25-OH, and 22(R)-OH cholesterol. 50, 51 Although several transcription factors (hepatocyte nuclear factors) are involved in the regulation of HSA gene expression, no data are available on the effects of compounds from Ox-LDL on this regulatory pathway. The albumin promoter is well known to interact with the hepatocyte nuclear factor-1 transcription factor, which plays a pivotal role in mediating liver-specific transcription of the gene. 52 Further specific studies should be addressed to determine whether sterol regulatory element binding protein 1 or 2 can interact with the albumin promoter or whether Ox-LDLs, lysoderivatives, and oxysterols can affect hepatocyte nuclear factor-1 levels in HepG2 cells.
It is tempting to extrapolate our findings to in vivo situations. Among the great number of pathologies possibly related to an alteration of the redox status, only a few, such as diabetes, have been linked to reduced transcription of the albumin gene in experimental models. 52 Moreover, when albuminuria occurs, such as in the nephrotic syndrome, hypoalbuminemia might actually be in part due to an inability of the liver to increase its albumin synthesis. These situations, which are related to a decrease in the antioxidant defense, could be due to the presence of high levels of circulating Ox-LDLs. 25, 53 This is also in line with observations that serum albumin decreases with age and cigarette smoking, 2 other situations well characterized by enhanced free radical attack. 20, 54, 55 In conclusion, Ox-LDLs induce a dose-dependent and significant decrease of albumin synthesis in HepG2 cells. This effect can be ascribed to oxysterols and LPC. Therefore, we propose that the occurrence of Ox-LDLs can be involved in the reduced synthesis of HSA that is often observed in hypercholesterolemia and diabetes. We are currently investigating this hypothesis in in vivo situations with the use of several models of high levels of circulating Ox-LDLs. Our results also demonstrate that antioxidants, by limiting the noxious influence of Ox-LDLs, may help to preserve the normal function of the liver through a normal synthesis rate of albumin. On the basis of epidemiological data and because of its key biological properties, a high circulating concentration of albumin seems to be a valuable goal that might be a target for new therapeutic strategies.
